Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Adenocarcinoma and IGF1[original query] |
---|
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3467-73. Suzuki Hideo, Li Yanan, Dong Xiaoqun, Hassan Manal M, Abbruzzese James L, Li Dongh |
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology 2010 Aug 139 (2): 464-73, 473.e1-3. Dong Xiaoqun, Javle Milind, Hess Kenneth R, Shroff Rachna, Abbruzzese James L, Li Dongh |
A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 2010 Jul 139 (1): 204-12.e3. McElholm Adrian R, McKnight Amy-Jane, Patterson Chris C, Johnston Brian T, Hardie Laura J, Murray Liam J, |
No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer. Cancer research and treatment : official journal of Korean Cancer Association 2011 Sep 43 (3): 189-94. Cho Yoon Young, Kim Jong Gwang, Chae Yee Soo, Sohn Sang Kyun, Kang Byung Woog, Moon Joon Ho, Jeon Seong Woo, Park Jun Seok, Park Jin Young, Choi Gyu Se |
The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation. International journal of molecular sciences 2016 May 17 (5): . Liu Tu-Chen, Hsieh Ming-Ju, Liu Ming-Che, Chiang Whei-Ling, Tsao Thomas Chang-Yao, Yang Shun- |
Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk. Journal of cellular biochemistry 2019 Apr 120 (4): 5510-5518. Tang Weifeng, Chen Shuchen, Liu Jun, Liu Chao, Wang Yafeng, Kang Mingqia |
Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis 2020 12 42 (3): 369-377. Dighe Shruti G, Chen Jianhong, Yan Li, He Qianchuan, Gharahkhani Puya, Onstad Lynn, Levine David M, Palles Claire, Ye Weimin, Gammon Marilie D, Iyer Prasad G, Anderson Lesley A, Liu Geoffrey, Wu Anna H, Dai James Y, Chow Wong-Ho, Risch Harvey A, Lagergren Jesper, Shaheen Nicholas J, Bernstein Leslie, Corley Douglas A, Prenen Hans, deCaestecker John, MacDonald David, Moayyedi Paul, Barr Hugh, Love Sharon B, Chegwidden Laura, Attwood Stephen, Watson Peter, Harrison Rebecca, Ott Katja, Moebus Susanne, Venerito Marino, Lang Hauke, Mayershofer Rupert, Knapp Michael, Veits Lothar, Gerges Christian, Weismüller Josef, Gockel Ines, Vashist Yogesh, Nöthen Markus M, Izbicki Jakob R, Manner Hendrik, Neuhaus Horst, Rösch Thomas, Böhmer Anne C, Hölscher Arnulf H, Anders Mario, Pech Oliver, Schumacher Brigitte, Schmidt Claudia, Schmidt Thomas, Noder Tania, Lorenz Dietmar, Vieth Michael, May Andrea, Hess Timo, Kreuser Nicole, Becker Jessica, Ell Christian, Ambrosone Christine B, Moysich Kirsten B, MacGregor Stuart, Tomlinson Ian, Whiteman David C, Jankowski Janusz, Schumacher Johannes, Vaughan Thomas L, Madeleine Margaret M, Hardie Laura J, Buas Matthew |
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer. Oncology research 2023 9 31 (6): 855-866. Sung Hee Lim, Hee Jin Cho, Kyoung-Mee Kim, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Young Suk Park, Hee Cheol Kim, Seung Tae K |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: